Meritförteckning

Testi

Meritförteckning

   Personal details:

• Mustjoki Satu Maarit, 08.01.1972 (date of birth), Finnish (nationality)
• ORCID: 0000-0002-0816-8241
• Website: www.helsinki.fi/hematology

Contact details:

• Address: Haartmaninkatu 8, 00290 Helsinki, Finland
• E-mail: [email protected]

Education:

• Adjunct professor (docent), Experimental hematology, Univ. of Helsinki, 2011
• Specialist in Clinical Chemistry (Laboratory Hematology), Univ. of Helsinki, Finland, 2008
• PhD, University of Helsinki, Finland, PhD Thesis with honor, 2001
• MD, University of Helsinki, Finland,1997

Current positions:

• 2019- Director of Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Finland
• 2017- Professor of Translational Hematology (100%), Univ. of Helsinki, Finland.
• 2018- Head of department, HUH Comprehensive Cancer Center, Helsinki Finland. Leader of biomarker projects in connection with clinical trials.

Previous work experience:

• 2015-2017 Research professor for the Finnish Cancer Institute
• 2015-2017 Deputy professor of Clinical Chemistry and Hematology (35% position), UH, Finland
• 2012-2015 Specialist doctor (5% position), HUH Comprehensive Cancer Center, Helsinki Finland
• 2010-2014   Senior Research fellow (Academy of Finland), HRUH, HUCH, Helsinki, Finland
• 2008-2010   Academy Clinical Researcher, HRUH, HUCH, Helsinki, Finland,
• 2007-2007 Resident in hematology, Dept. of Medicine, HUCH, Helsinki, Finland (4 months)
• 2006-2006   Clinical lecturer, Dept. of Clinical Chemistry, University of Helsinki, Finland (6 months)
• 2002-2006 Resident in Clinical Chemistry, Laboratory of Hematology, HUCH, Helsinki, Finland
• 2001-2002   Post-Doctoral researcher, Molecular Cancer Biology (Group prof. K. Alitalo), UH (12 months)
• 1995-2000 PhD student, Dept. of Virology (Cancer biology group prof. A. Vaheri), UH, Finland
• Career breaks: 2 children born in 2002 and 2004; Clinical specialization 2002-2008

Fellowships and awards

• City of Helsinki Science Award 2020
• ERC Proof-of-Concept awardee 2019
• Biomedicum Helsinki award 2018
• Nomination for the Helsinki Institute of Life Science (HiLife) Fellow group for years 2017-2020
• 2015 ERC (European Research Council) consolidator grant, 2 047 000 eur
• 2014 Instrumentarium Science foundation fellow award (100 000 eur)
• 2014 Nomination for the Biocentrum Helsinki research group for years 2014-2016
• 2010-2015 Senior research fellowship of the Academy of Finland
• 2008-2010 Clinical researcher fellowship from the Academy of Finland
  
  

Teaching experience

• Deputy prof. in Clinical Chemistry and Hematology responsible for undergraduate studies (medicine) and specialist training in the Univ. of Helsinki, Finland, 1.3.2015- (Curriculum, planning of the tuition, lecturing, educational materials)
• Vice director in the Doctoral program in Biomedicine and MD/Phd program 2018- (Curriculum, educational administration)
• Vice director in the Doctoral program in clinical research (Univ. of Helsinki) 2013-2017
• Lecturer in courses associated to Helsinki Biomedical Graduate school and to Specialist training in Internal Medicine and Clinical Chemistry 2010- (topics: Flow cytometry, scientific writing, laboratory hematology)
• Invited lecturer in the educational sessions in the international conferences (2013-2016)
• Doctor assistant and clinical lecturer, Department of Clinical Chemistry, University of Helsinki, Finland 1.8.2006-31.1.2007 (Planning of courses, lecturing, seminars, devising exams)
• Thesis committee member for 20 PhD students 2010-

Leadership and Supervision experience

• Leader of research work: Program leader of Translational Immunology research program, University of Helsinki 2019-2024; Consortium PI Heal-Art Academy of Finland Terva project 2018-2020; Consortium PI EraPerMed EU project 2019-2021; Board member of Nordic CML study group 2010-
• Supervisor in PhD thesis: PhD A. Kreutzman (2012, thesis with honor, “Antileukemic immune responses in CML”), PhD S. Hernesniemi (2012, “ Aberrant kinase activation as a therapy target: CML as a model disease”), MD, PhD H. Rajala (2014, best thesis of the year, “ Molecular pathogenesis of LGL leukemia”), PhD M. Ilander (2016, “ T and NK cell mediated immunity in CML”), PhD E. Andersson (2017, “Characterization of mature T-cell leukemias by  next-generation sequencing and drug sensitivity testing”), PhD P. Pietarinen (2017, “Effects of genotype and phenotype in personalized drug therapy”), MD, PhD M. El Missiry (2017, “Early Treatment Prediction and Immunological Effects of TKI Therapy in CML”), MD, PhD S. Söderlund (2017, “Clinical and Immunological studies in CML”). PhD H. Kuusanmäki (2018, “Targeting key survival signaling pathways in leukemia”), PhD P. Savola (2019, Somatic mutations in autoimmunity). Currently ongoing 12 PhD thesis supervisions.
• Supervisor in MSc and MD thesis: MSc M. Ilander (2011), MSc E. Andersson (2012), MD K. Penttinen (2012), MSc S. Bortoluzzi (2015), MD E. Vakkila (2016), MD J. Eskelinen (2016), MSc H. Hakanen (2016), V. Gasparini 2016 (Univ. of Padua, Italy), M. Lee (2017), P. Savola (2018), O. Dufva (2020).
• Supervisor in Post-Doc studies: PhD C. Hekim (2012-2014), PhD T. Kelkka (2013-), PhD G. Park (2015-2019), PhD A. Kreutzman (2015-), MD PhD M. Keränen (2015-), MD PhD Hanna Rajala (2016-), PhD B. Yadav (2017-2019), PhD M. Ilander (2016-2017), PhD K. Saeed (2018-2019), MD PhD M. Myllymäki (2019-), PhD K. Peltonen (2020-)
• Leader of research work: Program leader of Translational Immunology research program, University of Helsinki 2019-2024; Consortium PI Heal-Art Academy of Finland Terva project 2018-2020; Consortium PI EraPerMed EU project 2019-2021; Board member of Nordic CML study group 2010-

Memberships and positions of trust in scientific societies

• Member of the American Society of Hematology (ASH) scientific committee (myeloid neoplasia 2016-)
• Board member of the Nordic CML study group 2010- and of the Finnish Soc. of Hematol. 2006-2010
• Memberships in professional societies: Finnish Medical Association, 1993-; Finnish Society of Hematology, 2002-; The American Society of Hematology, 2008-; The European Society of Hematology, 2008-

Fellowships and awards

• City of Helsinki Science Award 2020
• ERC Proof-of-Concept awardee 2019
• Biomedicum Helsinki award 2018
• Nomination for the Helsinki Institute of Life Science (HiLife) Fellow group for years 2017-2020
• 2015 ERC (European Research Council) consolidator grant, 2 047 000 eur
• 2014 Instrumentarium Science foundation fellow award (100 000 eur)
• 2014 Nomination for the Biocentrum Helsinki research group for years 2014-2016
• 2010-2015 Senior research fellowship of the Academy of Finland
• 2008-2010 Clinical researcher fellowship from the Academy of Finland

Teaching experience

• Deputy prof. in Clinical Chemistry and Hematology responsible for undergraduate studies (medicine) and specialist training in the Univ. of Helsinki, Finland, 1.3.2015- (Curriculum, planning of the tuition, lecturing, educational materials)
• Vice director in the Doctoral program in Biomedicine and MD/Phd program 2018- (Curriculum, educational administration)
• Vice director in the Doctoral program in clinical research (Univ. of Helsinki) 2013-2017
• Lecturer in courses associated to Helsinki Biomedical Graduate school and to Specialist training in Internal Medicine and Clinical Chemistry 2010- (topics: Flow cytometry, scientific writing, laboratory hematology)
• Invited lecturer in the educational sessions in the international conferences (2013-2016)
• Doctor assistant and clinical lecturer, Department of Clinical Chemistry, University of Helsinki, Finland 1.8.2006-31.1.2007 (Planning of courses, lecturing, seminars, devising exams)
• Thesis committee member for 20 PhD students 2010-

Memberships and positions of trust in scientific societies

• Member of the American Society of Hematology (ASH) scientific committee (myeloid neoplasia 2016-)
• Board member of the Nordic CML study group 2010- and of the Finnish Soc. of Hematol. 2006-2010
• Memberships in professional societies: Finnish Medical Association, 1993-; Finnish Society of Hematology, 2002-; The American Society of Hematology, 2008-; The European Society of Hematology, 2008-

Key research funding:

• European Research Council: Proof of Concept and Consolidator Grant
• Academy of Finland: Health for Science, Academy Project funding
• ERA PerMed
• Cancer Society of Finland 

Bibliometrics (Web of Science)

Total citations: 5510

Citations/article: 20.56

H-index 37

Link to the full publication list: http://www.ncbi.nlm.nih.gov/pubmed/?term=mustjoki